Clot-Specific Streptokinase - The Third Generation Clot Buster
Implementing Organization
Institute of Microbial Technology (IMTECH)
Institute of Microbial Technology (IMTECH), Chandigarh
About
Process for the production of clot specific streptokinase which dissolve the pathological blood clot without plasminogen activation.
Patents
NA
Outcome / Output
A clot-buster drug with minimal side effects has been highly desirable. This function i.e. the ability to dissolve the pathological blood clot without plasminogen activation through the circulatory system is a highly coveted and premium property in any clot buster drug of choice.
Disclaimer:
Information available on this portal is sourced from various organizations and is provided for informational purposes only. Users are advised to verify details from the respective official sources.
Please enter your details
Please provide your name and email to continue. Your details are saved in this browser for future use.
Latest Updates
Loading…
⚠️
You are leaving this website
You are about to be redirected to an external website that is not operated by
India Science, Technology & Innovation (ISTI) Portal.
Institute of Microbial Technology (IMTECH)
Acces sibility Controls